Literature DB >> 25678143

Patterns of peripheral neuropathy in ART-naïve patients initiating modern ART regimen.

Anthony J Lee1, Ronald J Bosch, Scott R Evans, Kunling Wu, Taylor Harrison, Philip Grant, David B Clifford.   

Abstract

The purpose of this study was to evaluate associations of pre-ART CD4 with peripheral neuropathy (PN) and estimate the prevalence of PN in HIV-positive patients starting modern combination antiretroviral therapy (cART) regimens. ART-naïve subjects initiating cART were followed longitudinally and screened for signs/symptoms of PN. Lower pre-ART CD4 count was associated with post-ART PN. After 7 years (n = 117), the prevalence (95% CI) of PN and SPN were 31% (23, 40%) and 5% (2, 11%) with pre-ART CD4 count >250 copies/μL. PN continues to be identified in HIV-infected individuals on modern cART by targeted assessment but is generally without symptoms.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25678143      PMCID: PMC4624403          DOI: 10.1007/s13365-015-0327-1

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  27 in total

1.  Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort.

Authors:  Kenneth A Lichtenstein; Carl Armon; Anna Baron; Anne C Moorman; Kathleen C Wood; Scott D Holmberg
Journal:  Clin Infect Dis       Date:  2004-12-06       Impact factor: 9.079

2.  Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current cognitive and neurological status in human immunodeficiency virus type 1 infection--The Hawaii Aging with HIV Cohort.

Authors:  Victor Valcour; Priscilla Yee; Andrew E Williams; Bruce Shiramizu; Michael Watters; Ola Selnes; Robert Paul; Cecilia Shikuma; Ned Sacktor
Journal:  J Neurovirol       Date:  2006-10       Impact factor: 2.643

3.  HIV-related neurological syndromes reduce health-related quality of life.

Authors:  Rupang Pandya; Hartmut B Krentz; M John Gill; Christopher Power
Journal:  Can J Neurol Sci       Date:  2005-05       Impact factor: 2.104

4.  Antiretroviral use and other risks for HIV-associated neuropathies in an international cohort.

Authors:  C L Cherry; R L Skolasky; L Lal; J Creighton; P Hauer; S P Raman; R Moore; K Carter; D Thomas; G J Ebenezer; S L Wesselingh; J C McArthur
Journal:  Neurology       Date:  2006-03-28       Impact factor: 9.910

5.  HIV neuropathy natural history cohort study: assessment measures and risk factors.

Authors:  D M Simpson; D Kitch; S R Evans; J C McArthur; D M Asmuth; B Cohen; K Goodkin; M Gerschenson; Y So; C M Marra; R Diaz-Arrastia; S Shriver; L Millar; D B Clifford
Journal:  Neurology       Date:  2006-06-13       Impact factor: 9.910

6.  Markers of immune activation and viral load in HIV-associated sensory neuropathy.

Authors:  G Schifitto; M P McDermott; J C McArthur; K Marder; N Sacktor; D R McClernon; K Conant; B Cohen; L G Epstein; K Kieburtz
Journal:  Neurology       Date:  2005-03-08       Impact factor: 9.910

Review 7.  Neurological complications of HIV infection.

Authors:  Justin C McArthur; Bruce J Brew; Avi Nath
Journal:  Lancet Neurol       Date:  2005-09       Impact factor: 44.182

8.  Peripheral neuropathy in ART-experienced patients: prevalence and risk factors.

Authors:  Huichao Chen; David B Clifford; Lijuan Deng; Kunling Wu; Anthony J Lee; Ronald J Bosch; Sharon A Riddler; Ronald J Ellis; Scott R Evans
Journal:  J Neurovirol       Date:  2013-12-03       Impact factor: 2.643

9.  Class-sparing regimens for initial treatment of HIV-1 infection.

Authors:  Sharon A Riddler; Richard Haubrich; A Gregory DiRienzo; Lynne Peeples; William G Powderly; Karin L Klingman; Kevin W Garren; Tania George; James F Rooney; Barbara Brizz; Umesh G Lalloo; Robert L Murphy; Susan Swindells; Diane Havlir; John W Mellors
Journal:  N Engl J Med       Date:  2008-05-15       Impact factor: 91.245

10.  Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial.

Authors:  Jeffrey L Lennox; Raphael J Landovitz; Heather J Ribaudo; Ighovwerha Ofotokun; Lumine H Na; Catherine Godfrey; Daniel R Kuritzkes; Manish Sagar; Todd T Brown; Susan E Cohn; Grace A McComsey; Francesca Aweeka; Carl J Fichtenbaum; Rachel M Presti; Susan L Koletar; David W Haas; Kristine B Patterson; Constance A Benson; Bryan P Baugh; Randi Y Leavitt; James F Rooney; Daniel Seekins; Judith S Currier
Journal:  Ann Intern Med       Date:  2014-10-07       Impact factor: 25.391

View more
  8 in total

1.  Factors associated with distal symmetric polyneuropathies in adult Zambians: A cross-sectional, observational study of the role of HIV, non-antiretroviral medication exposures, and nutrition.

Authors:  Michelle Kvalsund; Takondwa Chidumayo; Johanna Hamel; David Herrmann; Douglas Heimburger; Amanda Peltier; Gretchen Birbeck
Journal:  J Neurol Sci       Date:  2018-02-22       Impact factor: 3.181

2.  Dissociable Contributions of Precuneus and Cerebellum to Subjective and Objective Neuropathy in HIV.

Authors:  Natalie M Zahr; Kilian M Pohl; Adolf Pfefferbaum; Edith V Sullivan
Journal:  J Neuroimmune Pharmacol       Date:  2019-02-11       Impact factor: 4.147

3.  Global HIV neurology: a comprehensive review.

Authors:  Kiran T Thakur; Alexandra Boubour; Deanna Saylor; Mitashee Das; David R Bearden; Gretchen L Birbeck
Journal:  AIDS       Date:  2019-02-01       Impact factor: 4.177

Review 4.  Neurologic Complications in Treated HIV-1 Infection.

Authors:  Nisha S Bhatia; Felicia C Chow
Journal:  Curr Neurol Neurosci Rep       Date:  2016-07       Impact factor: 5.081

5.  Medicaid trends in prescription opioid and non-opioid use by HIV status.

Authors:  Chelsea Canan; G Caleb Alexander; Richard Moore; Irene Murimi; Geetanjali Chander; Bryan Lau
Journal:  Drug Alcohol Depend       Date:  2019-02-13       Impact factor: 4.492

Review 6.  Update of HIV-Associated Sensory Neuropathies.

Authors:  Angela Aziz-Donnelly; Taylor B Harrison
Journal:  Curr Treat Options Neurol       Date:  2017-08-31       Impact factor: 3.598

7.  High-Risk Prescription Opioid Use Among People Living With HIV.

Authors:  Chelsea E Canan; Geetanjali Chander; Anne K Monroe; Kelly A Gebo; Richard D Moore; Allison L Agwu; G Caleb Alexander; Bryan Lau
Journal:  J Acquir Immune Defic Syndr       Date:  2018-07-01       Impact factor: 3.731

8.  Association Between Diagnoses of Chronic Noncancer Pain, Substance Use Disorder, and HIV-Related Outcomes in People Living With HIV.

Authors:  Cecile M Denis; Knashawn H Morales; Qufei Wu; David S Metzger; Martin D Cheatle
Journal:  J Acquir Immune Defic Syndr       Date:  2019-12-01       Impact factor: 3.731

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.